Synthesis of (+)-cis/(–)-trans-Lauthisan and (+)-cis/(+)-trans-Obtusan
dried, filtered, concentrated, and subjected to silica-gel flash
chromatography, yielding a 1.7:1.0 mixture of diastereoisomers 17a
(780 mg, 63% yield) as an oil. 1H NMR (300 MHz, CDCl3): δ =
135.3 (d), 135.9 (d) ppm. IR (film, NaCl plates): ν = 2934, 2862,
˜
1604, 1126 cm–1. LRMS (EI): m/z (%) = 167 (9) [M – 2C3H5
H]+, 109 (3), 83 (30). HRMS (EI): calcd. for C11H19O [M –
+
0.87 (dd, J = 6.1, 6.8 Hz, 7.5 H), 0.99 (m, 7.5 H), 1.27–1.47 (m, 23 2C3H5+H]+ 167.1436; found 167.1437.
H), 1.58–1.75 (m, 7 H), 2.33 (d, J = 1.96 Hz, 1.5 H), 2.36 (d, J =
Preparation of Dicobalt Hexacarbonyl Complex of (S)-3-[(R and S)-
2.1 Hz, 1 H), 4.00 (m, 5 H), 5.18 (m, 5 H), 5.57 (ddd, J = 2.0, 8.1,
17.7 Hz, 1.5 H), 5.79 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 9.3 (q), 9.5 (q), 14.0 (q), 22.6 (t), 25.1 (t), 25.2 (t), 28.5 (t), 28.9
(t), 29.1 (t), 29.2 (t), 31.8 (t), 34.8 (t), 35.5 (t), 67.2 (d), 68.5 (d),
72.7 (d), 72.7 (d), 78.7 (d), 80.0 (d), 83.5 (s), 83.8 (s), 115.9 (t),
Oct-7-en-4-yn-3-yloxy]non-1-ene (16a): The general procedure for
the preparation of cobalt-complexed propargyl alcohols described
above was applied to 17c (700 mg, 2.8 mmol), yielding 16a (1.51 g,
quantitative) as a dark-red oil.
Preparation of Dicobalt Hexacarbonyl Complex of (S)-4-[(R and S)-
Oct-7-en-4-yn-3-yloxy]non-1-ene (16b): The general procedure for
the preparation of cobalt-complexed propargyl alcohols described
above was applied to 17d (600 mg, 2.4 mmol), yielding 16b (1.29 g,
quantitative) as a dark-red oil.
117.3 (t), 138.7 (d), 139.4 (d) ppm. IR (film, NaCl plates): ν = 3311,
˜
2930, 2858, 1458, 1102 cm–1. C14H24O (208.3): calcd. C 80.71, H
11.61; found C 80.92, H 11.75.
(S)-4-[(R and S)-Pent-1-yn-3-yloxy]non-1-ene (17b): The general
procedure for the preparation of α,αЈ-disubstituted linear ethers de-
scribed above was applied to Co2(CO)6–1-octyn-3-ol (0.5 g,
5.9 mmol) and (S)-non-1-en-4-ol (18b; 4.2 g, 29.5 mmol), yielding
a 1.1:1.0 mixture of diastereoisomers 17b (799 mg, 65% yield) as
Dicobalt Hexacarbonyl Complexes of (2R and 2S,8S)-2-Ethyl-8-
hexyl-3,4-didehydro-5,8-dihydro-2H-oxocine (cis-15a and trans-15a):
To a stirred solution of cobalt complexes 16a (250 mg, 0.47 mmol)
in dry CH2Cl2 (470 mL, 0.001 ) was added the 2nd generation
Grubbs catalyst (120 mg, 0.14 mmol, 30 mol-%). The reaction was
warmed at 35 °C and kept at such a temperature until TLC showed
complete conversion. Then, the solvent was evaporated, and the
residue was purified by column chromatography yielding cis-15a
(73 mg, 31% yield) and trans-15a (124 mg, 52% yield). Data for
cis-15a: 1H NMR (400 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 3
H), 1.18 (dd, J = 7.3, 7.3 Hz, 3 H), 1.30–1.90 (m, 12 H), 3.45 (dd,
J = 7.9, 15.6 Hz, 1 H), 3.71 (m, 1 H), 4.11 (dd, J = 4.6, 8.3 Hz, 1
H), 4.53 (dd, J = 2.2, 9.7 Hz, 1 H), 5.55 (dd, J = 9.0, 10.0 Hz, 1
H), 6.08 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 11.3 (q),
13.8 (q), 22.3 (t), 25.0 (t), 29.0 (t), 30.6 (t), 31.5 (t), 31.9 (t), 36.2
(t), 75.4 (d), 83.8 (d), 99.5 (s), 101.4 (s), 131.6 (d), 136.3 (d) ppm.
Data for trans-15a: 1H NMR (400 MHz, CDCl3): δ = 0.85 (m, 6
H), 0.90–1.85 (m, 12 H), 3.50 (dd, J = 7.2, 17.4 Hz, 1 H), 3.80 (m,
1 H), 4.15 (m, 1 H), 4.45 (dd, J = 2.9, 9.0 Hz, 1 H), 5.55 (dd, J =
9.8, 9.8 Hz, 1 H), 6.18 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 11.3 (q), 13.8 (q), 22.3 (t), 25.0 (t), 29.0 (t), 30.6 (t), 31.5 (t),
31.9 (t), 36.2 (t), 75.4 (d), 83.8 (d), 101.4 (s), 131.5 (d), 136.3 (d)
ppm.
1
an oil. H NMR (400 MHz, CDCl3): δ = 0.86 (m, 6 H), 0.98 (ddd,
J = 2.4, 7.2, 7.2 Hz, 6 H), 1.24–1.73 (m, 20 H), 1.58 (s, 1 H), 2.22–
2.36 (m, 4 H), 3.57 (m, 2 H), 4.02 (m, 2 H), 5.04 (m, 4 H), 5.82
(m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 10.0 (q), 10.0
(q), 14.4 (q), 14.4 (q), 22.9 (t), 25.0 (t), 25.5 (t), 29.6 (t), 29.6 (t),
32.3 (t), 32.4 (t), 33.5 (t), 34.7 (t), 38.3 (t), 39.4 (t), 68.9 (d), 69.5
(d), 73.1 (d), 73.2 (d), 77.1 (d), 78.1 (d), 84.3 (s), 84.4 (s), 116.8 (t),
117.3 (t), 135.2 (d), 135.7 (d) ppm. IR (film, NaCl plates): ν = 3295,
˜
2927, 2854, 1158 cm–1.
Preparation of (S)-3-[(R and S)-Oct-7-en-4-yn-3-yloxy]non-1-ene
(17c) as a Representative Example for the Alkylation of Terminal
Alkynes with Allyl Bromide: To a stirred solution of terminal alkyne
17a (0.7 g, 3.4 mmol) in dry DMF (1.1 mL) was added K2CO3
(650 mg, 4.7 mmol) and copper(I) iodine (32 mg, 0.16 mmol) se-
quentially under an atmosphere of nitrogen at room temperature
After 10 min, allyl bromide (378 µL, 4.4 mmol) was added. The
reaction mixture was stirred for 40 h. Then, it was poured into H2O
and extracted with diethyl ether. The combined organic phase was
washed with brine, dried, and concentrated. The crude obtained
was purified by flash chromatography, yielding 17c (785 mg, 94%
yield) as an oil. 1H NMR (300 MHz, CDCl3): δ = 0.87 (dd, J =
6.0, 6.8 Hz, 10 H), 1.27 (m, 16 H), 1.64 (m, 5 H), 2.98 (ddd, J =
1.2, 3.2, 5.1 Hz, 3 H), 4.02 (m, 3 H), 5.11 (m, 6 H), 5.60 (m, 1 H),
5.80 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 9.5 (q), 9.7
(q), 14.0 (q), 22.6 (t), 22.6 (t), 23.0 (t), 25.1 (t), 25.3 (t), 28.8 (t),
29.1 (t), 29.2 (t), 31.8 (t), 34.8 (t), 35.5 (t), 62.3 (s), 67.7 (d), 69.0
(d), 78.4 (d), 79.5 (d), 81.5 (d), 81.6 (s), 82.2 (s), 82.5 (s), 115.6 (t),
115.8 (t), 115.8 (t), 116.9 (t), 132.5 (d), 132.6 (d), 139.0 (d), 139.7
Dicobalt Hexacarbonyl Complexes of (2R and 2S,9S)-2-Ethyl-9-pen-
tyl-3,4-didehydro-2,5,8,9-tetrahydrooxonine (cis-15b and trans-15b):
The same procedure used above to obtain compounds 15a was ap-
plied to 16a (250 mg, 0.47 mmol), yielding cis-15b (105 mg, 44%
yield) and trans-15b (116 mg, 49% yield). Data for cis-15b: 1H
NMR (400 MHz, CDCl3): δ = 0.94 (m, 3 H), 1.14 (dd, J = 7.6,
7.6 Hz, 3 H), 1.33–1.80 (m, 10 H), 1.93 (m, 1 H), 2.09 (m, 1 H),
2.73 (dd, J = 3.2, 11.2 Hz, 1 H), 3.41 (dd, J = 7.6, 14.8 Hz, 1 H),
3.78 (dd, J = 6.4, 15.2 Hz, 1 H), 3.91 (m, 1 H), 4.56 (dd, J = 3.4,
9.2 Hz, 1 H), 5.68 (m, 1 H), 5.94 (m, 1 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 11.2 (q), 14.4 (q), 22.9 (t), 26.5 (t), 31.7 (t),
32.3 (t), 32.3 (t), 32.7 (t), 35.1 (t), 80.1 (d), 82.6 (d), 99.6 (s), 102.1
(s), 129.7 (d), 130.2 (d) ppm. Data for trans-15b: 1H NMR
(400 MHz, CDCl3): δ = 0.94 (m, 3 H), 1.14 (m, 3 H), 1.37–1.78 (m,
10 H), 1.90 (m, 1 H), 2.07 (m, 1 H), 2.88 (m, 1 H), 3.50 (dd, J =
8, 15 Hz, 1 H), 3.74 (m, 2 H), 4.28 (dd, J = 2.8, 10.4 Hz, 1 H), 5.76
(m, 1 H), 5.94 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
11.8 (q), 14.4 (q), 22.9 (t), 27.2 (t), 31.9 (t), 32.3 (t), 32.4 (t), 32.8
(t), 34.7 (t), 71.5 (d), 79.5 (d), 100.0 (s), 102.5 (s), 129.3 (d), 133.1
(d) ppm.
(d) ppm. IR (film, NaCl plates): ν = 2931, 2858, 1729, 1060 cm–1.
˜
LRMS (EI): m/z (%) = 163 (24) [M – C6H13]+, 125 (35), 107 (100).
HRMS (EI): calcd. for C16H25O [M – CH3]+ 233.1905; found
233.1907.
(S)-4-[(R and S)-Oct-7-en-4-yn-3-yloxy]non-1-ene (17d): The gene-
ral procedure for the alkylation of terminal alkynes with allyl bro-
mide described above was applied to 17b (0.7 g, 3.4 mmol), yielding
1
17d (667 mg, 79% yield) as an oil. H NMR (400 MHz, CDCl3): δ
= 0.81 (dd, J = 6.5, 9 Hz, 6 H), 0.92 (ddd, J = 3, 9, 9 Hz, 6 H),
1.18–2.18 (m, 20 H), 2.98 (dd, J = 2.5, 2.5 Hz, 4 H), 3.52 (m, 2 H),
3.99 (m, 2 H), 4.93–5.04 (m, 6 H), 5.24 (ddd, J = 1.5, 1.5, 21 Hz,
2 H), 5.73 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 10.1 Isomerization of 2,8-Dialkyl Co2(CO)6–Cycloalkynic Ethers by
(q), 10.2 (q), 14.3 (q), 14.4 (q), 22.9 (t), 23.0 (t), 23.4 (t), 23.4 (t),
Montmorillonite K-10: To a solution of Co2(CO)6 complexes cis-
25.1 (t), 25.6 (t), 29.9 (t), 29.9 (t), 32.3 (t), 32.4 (t), 33.6 (t), 34.8 15a and trans-15a (1:1.7, 197 mg, 0.39 mmol) in CH2Cl2 (4 mL)
(t), 38.4 (t), 39.6 (t), 69.4 (d), 69.9 (d), 76.8 (d), 77.8 (d), 81.8 (s),
81.9 (s), 82.9 (s), 82.9 (s), 116.2 (t), 116.5 (t), 117.1 (t), 132.9 (d),
was added Montmorillonite K-10 (591 mg), and the mixture was
stirred overnight at room temperature Then, the mixture was fil-
Eur. J. Org. Chem. 2009, 554–563
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
561